BioSpecifics Technologies Corp. Reaches New 1-Year High at $27.90 (BSTC)
BioSpecifics Technologies Corp. (NASDAQ:BSTC)’s share price reached a new 52-week high during trading on Wednesday , StockRatingsNetwork.com reports. The company traded as high as $27.90 and last traded at $27.84, with a volume of 24,795 shares traded. The stock had previously closed at $27.28.
The stock’s 50-day moving average is $25.72 and its 200-day moving average is $24.18. The company has a market cap of $178.0 million and a price-to-earnings ratio of 40.18.
BioSpecifics Technologies Corp. (NASDAQ:BSTC) last issued its quarterly earnings data on Thursday, May 8th. The company reported $0.12 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.07 by $0.05. The company had revenue of $2.80 million for the quarter, compared to the consensus estimate of $2.46 million. On average, analysts predict that BioSpecifics Technologies Corp. will post $0.63 earnings per share for the current fiscal year.
In other BioSpecifics Technologies Corp. news, Director Henry Morgan sold 17,940 shares of the stock in a transaction that occurred on Wednesday, June 4th. The shares were sold at an average price of $27.00, for a total transaction of $484,380.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
BioSpecifics Technologies Corp. (NASDAQ:BSTC) is a biopharmaceutical company involved in the development of an injectable collagenase for multiple indications.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.